224 related articles for article (PubMed ID: 25609330)
21. [Interview with Dr. W. Wiebicke, Bremen. To treat early with anti-inflammatory drugs!].
Wiebicke W
MMW Fortschr Med; 2002 Feb; 144(8):12-3. PubMed ID: 11910814
[No Abstract] [Full Text] [Related]
22. [Treatment of bronchial asthma exacerbation].
Płusa T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():30-2. PubMed ID: 15524010
[TBL] [Abstract][Full Text] [Related]
23. [New perspectives in GINA Asthma Guideline 2006].
Gillissen A; Wirtz H; Hoheisel G
Med Klin (Munich); 2007 May; 102(5):399-403. PubMed ID: 17497092
[TBL] [Abstract][Full Text] [Related]
24. Effects of antileukotrienes in the treatment of asthma.
Barnes NC
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S73-6. PubMed ID: 10673231
[No Abstract] [Full Text] [Related]
25. Asthma.
Fanta CH
N Engl J Med; 2009 Mar; 360(10):1002-14. PubMed ID: 19264689
[No Abstract] [Full Text] [Related]
26. Pharmaceutical treatment strategies for childhood asthma.
Carlsen KH; Carlsen KC
Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):168-76. PubMed ID: 18317028
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacologic therapy of bronchial asthma].
Herjavecz I
Orv Hetil; 2003 Aug; 144(33):1639-40. PubMed ID: 14564926
[No Abstract] [Full Text] [Related]
28. Summaries for patients. Omalizumab therapy for patients with severe asthma.
Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
[No Abstract] [Full Text] [Related]
29. Pharmacogenetics of asthma.
Hawkins GA; Peters SP
Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic modulation of airway inflammation.
O'Byrne PM; Gauvreau GM; Wood LJ
Allergy; 1998; 53(45 Suppl):41-7. PubMed ID: 9788706
[No Abstract] [Full Text] [Related]
31. The utility of a multidomain assessment of steroid response for predicting clinical response to omalizumab.
Fleming L; Koo M; Bossley CJ; Nagakumar P; Bush A; Saglani S
J Allergy Clin Immunol; 2016 Jul; 138(1):292-294. PubMed ID: 26924468
[No Abstract] [Full Text] [Related]
32. [Evaluation of clinical practices in asthma].
Gaga M
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S31-10S33. PubMed ID: 17127959
[No Abstract] [Full Text] [Related]
33. Pharmacologic interventions to reduce the risk of asthma exacerbations.
O'Byrne PM
Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
[TBL] [Abstract][Full Text] [Related]
34. Outpatient management of bronchial asthma in adults.
Rosa JD; Chandy D; Aronow WS; DeLorenzo LJ
Compr Ther; 2008; 34(1):10-7. PubMed ID: 18681106
[TBL] [Abstract][Full Text] [Related]
35. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
[No Abstract] [Full Text] [Related]
36. Prescription patterns for asthma medications in children and adolescents with health care insurance in the United States.
Arellano FM; Arana A; Wentworth CE; Vidaurre CF; Chipps BE
Pediatr Allergy Immunol; 2011 Aug; 22(5):469-76. PubMed ID: 21771082
[TBL] [Abstract][Full Text] [Related]
37. New medications for asthma.
Cydulka RK; Jarvis HE
Emerg Med Clin North Am; 2000 Nov; 18(4):789-801. PubMed ID: 11130939
[TBL] [Abstract][Full Text] [Related]
38. Asthma treatment guidelines meet the real world.
Dahlén SE; Dahlén B; Drazen JM
N Engl J Med; 2011 May; 364(18):1769-70. PubMed ID: 21542748
[No Abstract] [Full Text] [Related]
39. [Consensus recommendations on drug treatment of bronchial asthma in children and adolescents. 1. Addendum (2003). Austrian Society for Pediatrics and Adolescent Medicine and Austrian Society for Lung Diseases and Tuberculosis].
Eber E; Frischer T; Götz M; Horak E; Kurz H; Riedler J; Schmitzberger R; Zach M
Wien Klin Wochenschr; 2003 Sep; 115(15-16):604-6. PubMed ID: 14531176
[No Abstract] [Full Text] [Related]
40. Prescribing patterns of anti-asthma drugs in pediatric patients.
Sun HL; Lue KH; Kao YH
Acta Paediatr Taiwan; 2005; 46(4):212-8. PubMed ID: 16381335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
